AMOXICILLINA E ACIDO CLAVULANICO IBIGEN

Medicinal product

(Invented) name

AMOXICILLINA E ACIDO CLAVULANICO IBIGEN

Active substance (s)

Amoksicilinas/Klavulano rūgštis

Strength

1000 mg/200 mg

Pharmaceutical form

milteliai injekciniam ar infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01CR02, Amoxicillin and beta-lactamase inhibitor

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-08-21

Date of renewal

Documents

2782_AMOXICILLINA E ACIDO CLAVULANICO IBIGEN inj_PL_2025-08-21.docx

2782_AMOXICILLINA E ACIDO CLAVULANICO IBIGEN inj_PZ_2025-08-21.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Flakone yra	1 vnt.
Amoksicilinas	1000 mg
Klavulano rūgštis	200 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
118334	104441	1104441	flakonas	N10		Receptinis	LT/L/25/2782/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-08-21	Registruotas